Quest Diagnostics (DGX) Cash from Investing Activities (2016 - 2026)
Quest Diagnostics has reported Cash from Investing Activities over the past 18 years, most recently at -$152.0 million for Q1 2026.
- Quarterly Cash from Investing Activities fell 32.17% to -$152.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$668.0 million through Mar 2026, up 72.73% year-over-year, with the annual reading at -$631.0 million for FY2025, 75.24% up from the prior year.
- Cash from Investing Activities was -$152.0 million for Q1 2026 at Quest Diagnostics, up from -$191.0 million in the prior quarter.
- Over five years, Cash from Investing Activities peaked at -$82.0 million in Q2 2022 and troughed at -$1.6 billion in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$169.0 million (2022), against an average of -$290.3 million.
- Biggest five-year swings in Cash from Investing Activities: tumbled 1426.17% in 2024 and later soared 87.69% in 2025.
- Tracing DGX's Cash from Investing Activities over 5 years: stood at -$174.0 million in 2022, then skyrocketed by 34.48% to -$114.0 million in 2023, then crashed by 340.35% to -$502.0 million in 2024, then surged by 61.95% to -$191.0 million in 2025, then grew by 20.42% to -$152.0 million in 2026.
- According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$152.0 million, -$191.0 million, and -$201.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.